Allscripts Announces Fourth Quarter and Fiscal Year 2021 Results
Allscripts Healthcare Solutions (MDRX) reported a fourth quarter 2021 GAAP diluted EPS of $0.68, with non-GAAP diluted EPS at $0.79. Bookings rose 21% to $219 million compared to Q4 2020. The company generated $66 million in cash flow from continuing operations, while total revenue increased to $392 million, up from $386 million in the same quarter last year. Net income for Q4 2021 was $87 million, a decrease from $728 million in Q4 2020, primarily due to prior year gains from divestitures. Looking forward, Allscripts anticipates 2022 consolidated free cash flow between $165 million and $175 million and revenue growth of 1% to 2%.
- Bookings increased 21% year-over-year to $219 million.
- Cash flow from continuing operations reached $66 million.
- Non-GAAP income from operations rose to $65 million from $47 million year-over-year.
- Adjusted EBITDA increased to $94 million from $77 million in Q4 2020.
- For 2021, consolidated free cash flow was $248 million compared to $12 million in 2020.
- GAAP net income declined to $87 million from $728 million in Q4 2020, driven by prior year divestiture gains.
- GAAP diluted EPS dropped to $0.68 from $4.82 in Q4 2020 due to the same divestiture impacts.
-
Fourth quarter GAAP diluted EPS of
$0.68 $0.79 -
Fourth quarter bookings of
$219 million 21% from the fourth quarter of 2020 -
Generated
$66 million
Bookings(1) were
Fourth quarter 2021 revenue was
On a GAAP basis in the fourth quarter of 2021, income from operations was
GAAP net income in the fourth quarter of 2021 totaled
GAAP diluted earnings per share in the fourth quarter of 2021 were
Adjusted EBITDA totaled
For the full year ended
Stock repurchases totaled
“Allscripts delivered another strong quarter, reporting significant year-over-year growth in bookings, operating income, Adjusted EBITDA, and free cash flow. 2021 was a year of forward momentum for our company, as we made considerable, positive gains winning with our clients, shareholders, and talent,” said
2022 Financial Outlook(2)
For the full year 2022,
-
Consolidated free cash flow from continuing operations between
$165 million $175 million -
Consolidated revenue growth of
1% to2%
Conference Call
A replay of the call will be available approximately two hours after the conclusion of the call, for a period of four weeks, on the Allscripts Investor Relations website or by calling +1 (877) 660-6853 or +1 (201) 612-7415 - Conference ID # 13726412.
Supplemental and non-GAAP financial information is also available at http://investor.allscripts.com.
Footnotes
(1) |
Bookings reflect the value of executed contracts for software, hardware and other client services on a continuing operations basis. |
|
(2) |
In providing financial guidance, the company does not reconcile Adjusted EBITDA and free cash flow to the corresponding GAAP financial measures. |
NOTE: All percentage changes described within this press release are calculated from full dollar amounts as illustrated in the accompanying financial statements and Allscripts Supplemental Financial Data Workbook, posted on the Investor Relations website. Rounding differences may occur when individually calculating percentages or totals from rounded amounts included within the press release body compared to full dollar amounts in the tables.
About
© 2022
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding our 2022 outlook, profitability initiatives, strategic priorities and client outcomes. These forward-looking statements are based on the current beliefs and expectations of
Certain factors that could cause our actual results to differ materially from those described in the forward-looking statements include, but are not limited to: our ability to achieve the margin targets associated with our margin improvement initiatives within the contemplated time periods, if at all; the magnitude, severity and duration of the COVID-19 pandemic, including the impacts of the pandemic, along with the impacts of our responses and the responses by governments and other businesses to the pandemic, on our business, our employees, our clients and our suppliers; security breaches resulting in unauthorized access to our or our clients’ computer systems or data, including denial-of-services, ransomware or other Internet-based attacks; the failure by Practice Fusion to comply with the terms of the settlement agreements with the
| Table 1 | ||||
| Condensed Consolidated Balance Sheets | ||||
| (In millions) | ||||
| (Unaudited) | ||||
2021 |
2020 |
|||
| ASSETS | ||||
| Current assets: | ||||
| Cash and cash equivalents |
|
|
||
| Restricted cash | 2.2 |
6.4 |
||
| Accounts receivable, net | 327.1 |
347.3 |
||
| Contract assets | 124.8 |
106.7 |
||
| Income tax receivable | 0.0 |
25.4 |
||
| Prepaid expenses and other current assets | 118.9 |
136.3 |
||
| Total current assets |
|
|
||
| Fixed assets, net | 47.9 |
72.2 |
||
| Software development costs, net | 172.1 |
193.2 |
||
| Intangible assets, net | 235.9 |
286.6 |
||
974.5 |
974.7 |
|||
| Deferred taxes, net | 6.6 |
5.8 |
||
| Contract assets - long-term | 56.8 |
43.7 |
||
| Right-of-use assets - operating leases | 68.9 |
96.6 |
||
| Other assets | 101.2 |
91.6 |
||
| Total assets |
|
|
||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
| Current liabilities: | ||||
| Accounts payable |
|
|
||
| Accrued expenses | 92.5 |
100.2 |
||
| Accrued compensation and benefits | 92.2 |
118.8 |
||
| Deferred revenue | 325.9 |
334.8 |
||
| Current operating lease liabilities | 19.6 |
22.3 |
||
| Current liabilities attributable to discontinued operations | 0.0 |
322.8 |
||
| Total current liabilities | 547.1 |
934.8 |
||
| Long-term debt | 350.1 |
167.6 |
||
| Deferred revenue | 4.4 |
3.4 |
||
| Deferred taxes, net | 16.6 |
18.2 |
||
| Long-term operating lease liabilities | 64.8 |
93.5 |
||
| Other liabilities | 34.1 |
33.9 |
||
| Total liabilities |
|
|
||
| Total stockholders’ equity |
|
|
||
| Total liabilities and stockholders’ equity |
|
|
||
| Table 2 | ||||||||||||
| Condensed Consolidated Statements of Operations | ||||||||||||
| (In millions, except per share amounts) | ||||||||||||
| (Unaudited) | ||||||||||||
| Three Months Ended |
Twelve Months Ended |
|||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||
| Revenue: | ||||||||||||
| Software delivery, support and maintenance |
|
|
|
|
|
|
|
|
||||
| Client services | 146.4 |
|
142.8 |
|
586.9 |
|
579.0 |
|
||||
| Total revenue | 391.7 |
|
386.4 |
|
1,503.0 |
|
1,502.7 |
|
||||
| Cost of revenue: | ||||||||||||
| Software delivery, support and maintenance | 69.9 |
|
71.3 |
|
278.4 |
|
288.1 |
|
||||
| Client services | 123.5 |
|
123.9 |
|
486.3 |
|
530.5 |
|
||||
| Amortization of software development and acquisition-related assets (a) | 29.3 |
|
30.2 |
|
118.7 |
|
118.4 |
|
||||
| Total cost of revenue | 222.7 |
|
225.4 |
|
883.4 |
|
937.0 |
|
||||
| Gross profit | 169.0 |
|
161.0 |
|
619.6 |
|
565.7 |
|
||||
| Selling, general and administrative expenses | 74.2 |
|
93.8 |
|
313.8 |
|
389.9 |
|
||||
| Research and development | 47.8 |
|
54.3 |
|
193.7 |
|
206.1 |
|
||||
| Asset impairment charges | 0.0 |
|
74.7 |
|
11.8 |
|
75.0 |
|
||||
| Amortization of intangible and acquisition-related assets | 5.6 |
|
6.3 |
|
23.1 |
|
25.6 |
|
||||
| Income (loss) from operations | 41.4 |
|
(68.1 |
) |
77.2 |
|
(130.9 |
) |
||||
| Interest expense, net (b) | (3.2 |
) |
(6.1 |
) |
(12.1 |
) |
(32.4 |
) |
||||
| Other | 67.0 |
|
(0.6 |
) |
96.7 |
|
14.0 |
|
||||
| Income (loss) before income taxes | 105.2 |
|
(74.8 |
) |
161.8 |
|
(149.3 |
) |
||||
| Income tax (provision) benefit | (17.9 |
) |
10.1 |
|
(27.9 |
) |
16.7 |
|
||||
| Income (loss) from continuing operations, net of tax | 87.3 |
|
(64.7 |
) |
133.9 |
|
(132.6 |
) |
||||
| Income (loss) from discontinued operations | 0.0 |
|
16.8 |
|
0.0 |
|
71.4 |
|
||||
| Gain (loss) on sale of discontinued operations | 0.0 |
|
1,156.5 |
|
0.6 |
|
1,156.5 |
|
||||
| Income tax (provision) from discontinued operations | 0.0 |
|
(380.8 |
) |
(0.1 |
) |
(394.9 |
) |
||||
| Income (loss) from discontinued operations, net of tax | 0.0 |
|
792.5 |
|
0.5 |
|
833.0 |
|
||||
| Net Income (loss) attributable to |
|
|
|
|
|
|
|
|
||||
| Income (loss) from continuing operations per share - basic |
|
|
( |
) |
|
|
( |
) |
||||
| Income (loss) from discontinued operations per share - basic |
|
|
|
|
|
|
|
|
||||
| Income (loss) per share - basic |
|
|
|
|
|
|
|
|
||||
| Income (loss) from continuing operations per share - diluted |
|
|
( |
) |
|
|
( |
) |
||||
| Income (loss) from discontinued operations per share - diluted |
|
|
|
|
|
|
|
|
||||
| Income (loss) per share - diluted |
|
|
|
|
|
|
|
|
||||
| Weighted average common shares outstanding: | ||||||||||||
| Basic | 120.1 |
|
150.9 |
|
130.1 |
|
159.3 |
|
||||
| Diluted | 127.8 |
|
150.9 |
|
138.7 |
|
159.3 |
|
||||
| Three Months Ended |
Twelve Months Ended |
|||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||
| (a) Amortization of software development and acquisition-related assets includes: | ||||||||||||
| Amortization of capitalized software development costs | 22.5 |
|
22.7 |
|
91.3 |
|
86.3 |
|
||||
| Amortization of acquisition-related intangible assets | 6.8 |
|
7.5 |
|
27.4 |
|
32.1 |
|
||||
| Total amortization of software development and acquisition-related assets |
|
|
|
|
|
|
|
|
||||
| (b) Interest expense, net is comprised of the following for the periods presented: | ||||||||||||
| Interest expense | (1.6 |
) |
(4.0 |
) |
(5.7 |
) |
(18.1 |
) |
||||
| Interest income | 0.3 |
|
0.3 |
|
1.1 |
|
1.7 |
|
||||
| Non-cash charges to interest expense | (1.9 |
) |
(2.4 |
) |
(7.5 |
) |
(16.0 |
) |
||||
| Interest expense, net |
( |
) |
( |
) |
( |
) |
( |
) |
||||
| Table 3 | ||||||||||||
| Condensed Consolidated Statements of Cash Flows | ||||||||||||
| (In millions) | ||||||||||||
| (Unaudited) | ||||||||||||
| Three Months Ended |
Twelve Months Ended |
|||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||
| Cash flows from operating activities: | ||||||||||||
| Net income (loss) |
|
|
|
|
|
|
|
|
||||
| Less: Income(loss) from discontinued operations | 0.0 |
|
792.5 |
|
0.5 |
|
833.0 |
|
||||
| Income (loss) from continuing operations |
|
|
( |
) |
|
|
( |
) |
||||
| Non-cash adjustments to net income (loss): | ||||||||||||
| Depreciation and amortization | 43.1 |
|
46.4 |
|
176.1 |
|
192.3 |
|
||||
| Non-cash lease expense, net | (0.8 |
) |
0.9 |
|
(3.8 |
) |
1.4 |
|
||||
| Stock-based compensation expense | 9.3 |
|
8.1 |
|
35.2 |
|
34.0 |
|
||||
| Deferred Taxes | (0.4 |
) |
(6.2 |
) |
(2.1 |
) |
(3.3 |
) |
||||
| Impairment of assets and long-term investments | 0.0 |
|
74.7 |
|
11.8 |
|
76.6 |
|
||||
| Gain on sale of businesses, net | 0.0 |
|
0.0 |
|
(8.4 |
) |
0.0 |
|
||||
| Other (income) loss, net | (61.4 |
) |
(4.9 |
) |
(70.9 |
) |
(23.1 |
) |
||||
| Total non-cash adjustments to net income (loss) | (10.2 |
) |
119.0 |
|
137.9 |
|
277.9 |
|
||||
| Cash impact of changes in operating assets and liabilities: | ||||||||||||
| Assets | (0.3 |
) |
(63.9 |
) |
12.8 |
|
0.7 |
|
||||
| Liabilities | (10.5 |
) |
65.2 |
|
(36.3 |
) |
13.5 |
|
||||
| Accrued DOJ settlement | 0.0 |
|
(58.4 |
) |
0.0 |
|
(147.2 |
) |
||||
| Total cash impact of changes on operating assets and liabilities | (10.8 |
) |
(57.1 |
) |
(23.5 |
) |
(133.0 |
) |
||||
| Net cash provided by (used in) operating activities - Continuing operations | 66.3 |
|
(2.8 |
) |
248.3 |
|
12.3 |
|
||||
| Net cash provided by (used in) operating activities - Discontinued operations | (1.2 |
) |
(175.8 |
) |
(323.7 |
) |
(119.0 |
) |
||||
| Net cash provided by (used in) operating activities | 65.1 |
|
(178.6 |
) |
(75.4 |
) |
(106.7 |
) |
||||
| Cash flows from investing activities: | ||||||||||||
| Capital expenditures | (0.7 |
) |
(9.2 |
) |
(5.3 |
) |
(17.0 |
) |
||||
| Capitalized software | (17.8 |
) |
(16.3 |
) |
(73.3 |
) |
(88.0 |
) |
||||
| Sale of businesses and other investments, net of cash divested and distributions received | 61.2 |
|
1,710.0 |
|
68.8 |
|
1,734.9 |
|
||||
| Purchases of equity securities, other investments and related intangible assets, net | 0.0 |
|
(3.2 |
) |
(2.4 |
) |
(7.1 |
) |
||||
| Cash provided by (used in) investing activities - Continuing Operations | 42.7 |
|
1,681.3 |
|
(12.2 |
) |
1,622.8 |
|
||||
| Cash provided by (used in) investing activities - Discontinued Operations | 0.0 |
|
(1.2 |
) |
0.0 |
|
(7.6 |
) |
||||
| Net cash provided by (used in) investing activities | 42.7 |
|
1,680.1 |
|
(12.2 |
) |
1,615.2 |
|
||||
| Cash flows from financing activities: | ||||||||||||
| Taxes paid related to net share settlement of equity awards | (0.1 |
) |
(0.4 |
) |
(14.0 |
) |
(5.9 |
) |
||||
| Payments for issuance costs on |
0.0 |
|
0.0 |
|
0.0 |
|
(0.8 |
) |
||||
| Repayment of Convertible Senior Notes | 0.0 |
|
0.0 |
|
0.0 |
|
(352.3 |
) |
||||
| Credit facility payments | (25.0 |
) |
(1,140.0 |
) |
(75.0 |
) |
(1,315.0 |
) |
||||
| Credit facility borrowings, net of issuance costs | 0.0 |
|
230.0 |
|
250.0 |
|
903.6 |
|
||||
| Repurchase of common stock | (108.5 |
) |
(279.6 |
) |
(417.5 |
) |
(334.9 |
) |
||||
| Payment of acquisition and other financing obligations | 0.0 |
|
0.0 |
|
(2.4 |
) |
(4.4 |
) |
||||
| Net cash provided by (used in) financing activities | (133.6 |
) |
(1,190.0 |
) |
(258.9 |
) |
(1,109.7 |
) |
||||
| Effect of exchange rate changes on cash and cash equivalents | 0.0 |
|
1.1 |
|
(0.5 |
) |
1.2 |
|
||||
| Net increase (decrease) in cash and cash equivalents | (25.8 |
) |
312.6 |
|
(347.0 |
) |
400.0 |
|
||||
| Cash, cash equivalents and restricted cash, beginning of period | 216.3 |
|
224.9 |
|
537.5 |
|
137.5 |
|
||||
| Cash, cash equivalents and restricted cash, end of period |
|
|
|
|
|
|
|
|
||||
| Table 4 | |||||||||||
| Condensed Non-GAAP Financial Information | |||||||||||
| (In millions, except per share amounts and percentages) | |||||||||||
| (Unaudited) | |||||||||||
| Three Months Ended |
Twelve Months Ended |
||||||||||
2021 |
2020 |
2021 |
2020 |
||||||||
| Gross profit, as reported |
|
|
|
|
|
|
|
|
|||
| Acquisition-related amortization | 6.8 |
|
7.5 |
|
27.4 |
|
32.1 |
|
|||
| Stock-based compensation expense | 1.4 |
|
1.5 |
|
5.6 |
|
6.0 |
|
|||
| Restructuring and other | 0.0 |
|
(0.1 |
) |
0.0 |
|
2.8 |
|
|||
| Total non-GAAP gross profit |
|
|
|
|
|
|
|
|
|||
| Income (loss) from operations, as reported |
|
|
( |
) |
|
|
( |
) |
|||
| Acquisition-related amortization | 12.5 |
|
13.8 |
|
50.6 |
|
57.8 |
|
|||
| Stock-based compensation expense | 11.0 |
|
9.5 |
|
43.5 |
|
38.4 |
|
|||
| Restructuring and other | 0.0 |
|
91.5 |
|
(0.0 |
) |
141.2 |
|
|||
| Total non-GAAP income from operations |
|
|
|
|
|
|
|
|
|||
| Net income (loss) attributable to |
|
|
|
|
|
|
|
|
|||
| Loss (income) from discontinued operations | 0.0 |
|
(16.8 |
) |
0.0 |
|
(71.4 |
) |
|||
| (Gain) on sale of business, net from discontinued operations | 0.0 |
|
(1,156.5 |
) |
(0.6 |
) |
(1,156.5 |
) |
|||
| Income tax provision from discontinued operations | 0.0 |
|
380.8 |
|
0.1 |
|
394.9 |
|
|||
| Income (loss) from continuing operations, net of tax |
|
|
( |
) |
|
|
( |
) |
|||
| Acquisition-related amortization | 12.5 |
|
13.8 |
|
50.6 |
|
57.7 |
|
|||
| Stock-based compensation expense | 11.0 |
|
9.5 |
|
43.5 |
|
38.4 |
|
|||
| Restructuring and other | 0.0 |
|
91.5 |
|
(0.0 |
) |
141.2 |
|
|||
| Non-cash charges to interest expense and other | 1.4 |
|
1.2 |
|
0.2 |
|
16.1 |
|
|||
| Tax rate alignment | (13.3 |
) |
(19.9 |
) |
(33.6 |
) |
(41.7 |
) |
|||
| Non-GAAP net income attributable to |
|
|
|
|
|
|
|
|
|||
| Non-GAAP effective tax rate | 24 |
% |
24 |
% |
24 |
% |
24 |
% |
|||
| Weighted shares outstanding - basic | 120.1 |
|
150.9 |
|
130.1 |
|
159.3 |
|
|||
| Weighted shares outstanding - diluted | 127.8 |
|
155.9 |
|
138.7 |
|
162.0 |
|
|||
| Less effect of convertible note hedges | (2.5 |
) |
0.0 |
|
(2.8 |
) |
0.0 |
|
|||
| Non-GAAP Weighted shares outstanding - diluted | 125.3 |
|
155.9 |
|
135.9 |
|
162.0 |
|
|||
| GAAP Income (loss) from continuing operations per share - diluted |
|
|
( |
) |
|
|
( |
) |
|||
| Non-GAAP Income (loss) per share - diluted |
|
|
|
|
|
|
|
|
|||
| Table 5 | ||||||||||||
| Non-GAAP Financial Information - Adjusted EBITDA | ||||||||||||
| (In millions, except percentages) | ||||||||||||
| (Unaudited) | ||||||||||||
| Three Months Ended |
Twelve Months Ended |
|||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||
| Income (loss) from operations, as reported |
|
|
( |
) |
|
|
( |
) |
||||
| Plus: | ||||||||||||
| Depreciation and amortization | 41.3 |
|
43.9 |
|
168.6 |
|
176.0 |
|
||||
| Asset impairment charges | 0.0 |
|
0.0 |
|
11.8 |
|
0.0 |
|
||||
| Stock-based compensation expense | 11.0 |
|
9.5 |
|
43.5 |
|
38.4 |
|
||||
| Restructuring and other | 0.0 |
|
91.5 |
|
0.0 |
|
141.2 |
|
||||
| Adjusted EBITDA |
|
|
|
|
|
|
|
|
||||
| Adjusted EBITDA margin (a) | 23.9 |
% |
19.9 |
% |
20.0 |
% |
15.0 |
% |
||||
| (a) Adjusted EBITDA margin is calculated by dividing adjusted EBITDA by revenue. | ||||||||||||
| Table 6 | ||||||||||||
| Non-GAAP Financial Information - Free Cash Flow | ||||||||||||
| (In millions) | ||||||||||||
| (Unaudited) | ||||||||||||
| Three Months Ended |
Twelve Months Ended |
|||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||
| Net cash provided by (used in) operating activities - continuing operations |
|
|
( |
) |
|
|
|
|
||||
| Cash flows from investing activities: | ||||||||||||
| Capital expenditures | (0.7 |
) |
(9.2 |
) |
(5.3 |
) |
(17.0 |
) |
||||
| Capitalized software | (17.8 |
) |
(16.3 |
) |
(73.3 |
) |
(88.0 |
) |
||||
| Free cash flow |
|
|
( |
) |
|
|
( |
) |
||||
Explanation of Non-GAAP Financial Measures
- Non-GAAP gross profit consists of GAAP gross profit, as reported, and excludes acquisition-related amortization; stock-based compensation expense and restructuring and other costs. Non-GAAP gross margin consists of non-GAAP gross profit as a percentage of revenue in the applicable period. Reconciliations to GAAP gross profit are found in Table 4 within this press release.
- Non-GAAP income from operations consists of GAAP income (loss) from operations, as reported, and excludes acquisition-related amortization; stock-based compensation expense; and restructuring and other costs. Reconciliations to GAAP income (loss) from operations are found in Table 4 within this press release.
- Adjusted EBITDA is a non-GAAP measure and consists of GAAP income/(loss) from operations, as reported, and adjusts for: depreciation and amortization; asset impairment charges; stock-based compensation expense; and restructuring and other costs. Reconciliations to GAAP income/(loss) from operations are found in Table 5 within this press release.
- Adjusted EBITDA margin is a non-GAAP measure that is calculated by dividing Adjusted EBITDA by revenue. See the reconciliations in Table 5 within this press release with respect to Adjusted EBITDA.
-
Non-GAAP effective income tax rate is based on non-GAAP pre-tax earnings and consists of the statutory federal income tax rate,
Allscripts effective state income tax rate and adjustments for permanent differences.
-
Non-GAAP net income attributable to
Allscripts Healthcare Solutions, Inc. consists of GAAP net income/(loss) from continuing operations, as reported, and adds back acquisition-related amortization; stock-based compensation expense; restructuring and other costs; and non-cash charges to interest expense and other. Non-GAAP net income also includes a GAAP to non-GAAP tax rate alignment adjustment. Reconciliations to GAAP net income/(loss) attributable toAllscripts Healthcare Solutions, Inc. are found in Table 4 within this press release.
-
Non-GAAP diluted weighted shares outstanding consists of diluted weighted shares outstanding, as reported, less the effect of the capped call hedges related to the
0.875% Convertible Notes.
- Non-GAAP diluted earnings per share consist of non-GAAP net income, as defined above, divided by non-GAAP diluted weighted shares outstanding, as defined above, during the applicable period.
- Free cash flow consists of GAAP cash flows from continuing operations in the applicable period, net of capital expenditures and capitalized software costs. Reconciliations to GAAP cash flows from continuing operations are found in Table 6 within this press release.
Acquisition-Related Amortization. Acquisition-related amortization expense is a non-cash expense arising primarily from the acquisition of intangible assets in connection with acquisitions or investments.
Stock-Based Compensation Expense. Stock-based compensation expense is a non-cash expense arising from the grant of stock-based awards.
Restructuring and Other Costs. Restructuring and other costs relate to certain legal proceedings and investigations, consulting, severance, incentive compensation and other charges incurred in connection with activities that are considered not reflective of our core business. Other costs also include non-cash impairment charges based on management’s assessment of the likelihood of near-term recovery of the investments’ value.
Asset Impairment Charges. Asset impairment charges reflect non-cash charges related to the write-offs of deferred costs related to our private cloud hosting operations.
Non-Cash Charges to Interest Expense and Other. Non-cash charges to interest expense include the amortization of the fair value of the conversion option embedded in the
Tax Rate Alignment. Tax rate alignment aligns the applicable period’s effective tax rate to the expected annual non-GAAP effective tax rate.
Management also believes that non-GAAP gross profit, income from operations, effective income tax rate, net income, diluted earnings per share, Adjusted EBITDA, Adjusted EBITDA margin and free cash flow provide useful supplemental information to management and investors regarding the underlying performance of
Management also uses this information internally for forecasting and budgeting, as it believes that these measures are indicative of core operating results. In addition, management may use non-GAAP gross profit, operating income, net income, diluted earnings per share, Adjusted EBITDA and/or Adjusted EBITDA margin to measure achievement under
View source version on businesswire.com: https://www.businesswire.com/news/home/20220222006289/en/
Investors:
312-506-1237
Jenny.Gelinas@allscripts.com
Media:
312-447-2466
concetta.rasiarmos@allscripts.com
Source:
FAQ
What were Allscripts' fourth quarter 2021 earnings per share?
How much did Allscripts' bookings grow compared to the previous year?
What is Allscripts' financial outlook for 2022?
What were Allscripts' cash flow results for the fourth quarter of 2021?
How did Allscripts' revenue change in the fourth quarter of 2021?
